MP Biomedicals facility in India is awarded both ISO 9001:2015 and WHO GMP certification
Sep 18, 2020
MP Biomedicals proudly announces the recent award of ISO 9001:2015 and WHO GMP certifications for manufacturing facility located in Navi Mumbai, in Maharashtra state of India.
The manufacturing facility accounts for production of cell culture media, buffers, solutions, sterile water for injection, and many more. This moves MP Biomedicals to support the global demands and requirements of the research and manufacturing in labs and industries worldwide.
Some of the highlight manufactured products support ongoing global efforts to battle COVID-19, such as Hank’s Buffer and Gentamicin Solution – all part of the COVID-19 Essentials under MP Biomedicals umbrella of offerings.
The 2,132 square meters and four-floors of manufacturing facility features clean rooms for production and packaging, with commercial-scale utility systems and fully equipped quality-controlled laboratories, along with separate temperature-controlled storage rooms.
Central to the success of MP Biomedicals is the quality of our people and our products. These certifications affirm not only the quality standards of our products, but also the quality of the services and the work of the professionals from our facilities worldwide.
Clients are assured global quality products with high consistency to support their manufacturing and research needs in Pharmaceutical and Diagnostic industries. Supported by qualified team of QA and QC professionals, MP Biomedicals meets highly stringent requirements with complete documentation and traceability.
MP Biomedicals understands the challenges of supplying custom manufacturing, specialized packaging and just-in-time delivery – being the preferred Total Supply Chain Partner for client’s global manufacturing needs.
MP Biomedicals is a worldwide corporation developing, manufacturing and distributing products for the life science, in vitro diagnostics (IVD), fine chemicals and dosimetry markets. Through our global operational network, we provide research and industrial communities with innovative, quality tools to aid them in their quest for scientific excellence. MP Biomedicals was founded in 1959 (ICN Pharmaceuticals, developed Ribavirin) with Global headquarter in Solon, Ohio in USA and APAC HQ office in Singapore.